FDA Approved: SEVELAMER CARBONATE — Supplemental Application (Bionpharma Inc.)

View source ↗

Summary

FDA approved a supplemental application for Sevelamer Carbonate submitted by Bionpharma Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease
• Hyperphosphatemia

Drugs mentioned

• SEVELAMER CARBONATE (sevelamer carbonate)

Snippet

SUPPL AP for SEVELAMER CARBONATE (SEVELAMER CARBONATE)